Single PET Scan Could Replace Multiple Modalities in Detecting Blood Clots
By MedImaging International staff writers Posted on 14 Sep 2015 |
Image: The whole body of a rat can be imaged for blood clots with one PET scan, overlaid here on an MRI image, using the FBP8 probe. The arrow points to a blood clot (Photo courtesy of the American Chemical Society).
Researchers have presented an experimental technique that could be used to discover blood clots using a single, fast, whole-body scan, at the 250th National Meeting and Exposition of the American Chemical Society (ACS; Boston, MA, USA).
Blood clots can trigger a heart attack, a stroke, or other dangerous complications, and using existing methods a clinician may need to perform an ultrasound scan to find clots in a patient’s legs or carotid arteries, Computed Tomography to scan the lungs, and Magnetic Resonance Imaging (MRI) to find clots in cardiac arteries.
The new technique was tested in rats using a probe created by attaching a radionuclide to a peptide. The peptide in the probe binds to the protein fibrin found in blood clots. The radionuclide in the probe can be detected anywhere in a patient’s body using a single Positron Emission Tomography (PET) scan. Researchers experimented with various radionuclides and peptides, to find the brightest PET signal when scanning for blood clots. The best-performing probe that the research team found was Fibrin Binding Probe #8 (FBP8), combined with a copper-64 radionuclide.
The research team from the Athinoula A. Martinos Center for Biomedical Imaging in the Massachusetts General Hospital (MGH; Charlestown, MA, USA) is planning to begin human trials of the probe in fall 2015, but expect that it could take up to five more years of research before the new technique is ready for routine clinical screening.
Peter Caravan, PhD, said, “Patients could end up being scanned multiple times by multiple techniques in order to locate a clot. We sought a method that could detect blood clots anywhere in the body with a single whole-body scan. The probes all had a similar affinity to fibrin in vitro, but in rats, their performances were quite different. The best probe was the one that was the most stable. Of course, the big question is, ‘How well will these perform in patients?’”
Related Links:
Massachusetts General Hospital
American Chemical Society
Blood clots can trigger a heart attack, a stroke, or other dangerous complications, and using existing methods a clinician may need to perform an ultrasound scan to find clots in a patient’s legs or carotid arteries, Computed Tomography to scan the lungs, and Magnetic Resonance Imaging (MRI) to find clots in cardiac arteries.
The new technique was tested in rats using a probe created by attaching a radionuclide to a peptide. The peptide in the probe binds to the protein fibrin found in blood clots. The radionuclide in the probe can be detected anywhere in a patient’s body using a single Positron Emission Tomography (PET) scan. Researchers experimented with various radionuclides and peptides, to find the brightest PET signal when scanning for blood clots. The best-performing probe that the research team found was Fibrin Binding Probe #8 (FBP8), combined with a copper-64 radionuclide.
The research team from the Athinoula A. Martinos Center for Biomedical Imaging in the Massachusetts General Hospital (MGH; Charlestown, MA, USA) is planning to begin human trials of the probe in fall 2015, but expect that it could take up to five more years of research before the new technique is ready for routine clinical screening.
Peter Caravan, PhD, said, “Patients could end up being scanned multiple times by multiple techniques in order to locate a clot. We sought a method that could detect blood clots anywhere in the body with a single whole-body scan. The probes all had a similar affinity to fibrin in vitro, but in rats, their performances were quite different. The best probe was the one that was the most stable. Of course, the big question is, ‘How well will these perform in patients?’”
Related Links:
Massachusetts General Hospital
American Chemical Society
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment